von Tobias Borgers | Feb. 27, 2021 | Frewitt
Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn. In September, Gilead signed a definitive merger agreement to acquire all the outstanding shares of Immunomedics at a price of $88 per...
von Tobias Borgers | Feb. 27, 2021 | Bosch
The market research report is the new statistical data source added by Contrive Datum Insights. It uses several approaches for analyzing the data of the target market such as primary and secondary research methodologies. It includes investigations based on historical...
von Tobias Borgers | Jan. 29, 2021 | Fette
The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027. Continuous manufacturing in the pharmaceuticals industry is a...
von Tobias Borgers | Jan. 25, 2021 | Gerteis
Global Pharmaceutical Roller Compactors Market Growth 2020-2025 combines the essentials, definitions, categorization, and analysis of significant features. A latest extensive, professional market study brings data on the Pharmaceutical Roller Compactors market which...
von Tobias Borgers | Jan. 25, 2021 | Frewitt
There are several factors at play that explain this reticence to accept change in the pharma industry. For one, regulatory overhead is high and some organisations are reluctant to take on risk. Changing processes means re-evaluating challenges, and there are...
von Tobias Borgers | Jan. 24, 2021 | Bosch
Overview Of Continuous Manufacturing Industry 2020-2025: This has brought along several changes in This report also covers the impact of COVID-19 on the global market. The Continuous Manufacturing market is segmented on the basis of product, application, end user, and...